Request for Comments - Standardized Format for the Part D Medication Therapy Management Program Comprehensive Medication Review Summary
Guidance for in this document, we describe proposed changes to the standardized format. We are providing plan sponsors, advocates, and other stakeholders the opportunity to comment ahead of the PRA process.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: November 18, 2013
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.